VEGF Inhibitor Implant Preserves Visual Acuity, Retinal Anatomy in Wet AMD

(MedPage Today) — DENVER — A sustained-release VEGF inhibitor implant outperformed standard anti-VEGF therapy for maintaining visual acuity in neovascular, or wet, age-related macular degeneration (AMD), showed a randomized trial reported here…